The European Medicines Agency (EMA) has published a reflection paper regarding the use of extrapolation when developing medicinal products for paediatric use. The main focus of the reflection paper is ...
The Centers for Medicare and Medicaid Services (CMS) published its final rule regarding the Medicare Advantage (MA) Risk Adjustment Data Validation (RADV) program in early February 2023.[1] Among ...
Specialists define and discuss extrapolation, along with the importance of strong data in specific disease states. This is a video synopsis/summary of a panel discussion involving Ryan Haumschild, ...
Researchers at Shanghai Jiao Tong University have made a groundbreaking discovery in the field of Temporal Knowledge Graphs ...
Click here to view the full version of this article. Recently, both insurance and pension regulators in Europe have been moving away from market-consistent valuations of long-dated liabilities. Market ...
Some of the most widely used biologic medicines in oncology have patents about to expire, opening the market to noninnovative versions of these drugs. There are already many examples of price ...
Sankhyā: The Indian Journal of Statistics, Series A (1961-2002), Vol. 64, No. 3, In Memory of D. Basu, Part 1 (Oct., 2002), pp. 640-652 (13 pages) The m out of n bootstrap, with or without replacement ...
The final guidance explains some principles for developing biosimilars and establishes some rules about extrapolation across indications for various medical conditions. EMA released final guidance on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results